COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 262: Articles 2611-2620  | Next

A critical reexamination of recovered SARS-CoV-2 sequencing data
Debarre, F., Hensel, Z.
10.1101/2024.02.15.580500 — Posted: 2024-02-16
Robust Neutralization of SARS-CoV-2 Variants Including JN.1 and BA.2.87.1 by Trivalent XBB Vaccine-Induced Antibodies
Wang, X., Jiang, S., Ma, W., Li, C., Liu, C., Xie, F., Zhu, J., Zhan, Y., Jiang, S., Li, M., Zhang, Y., Wang, P.
10.1101/2024.02.16.580615 — Posted: 2024-02-16
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
Jernbom Falk, A., Skoglund, L., Pin, E., Sjöberg, R., Tegel, H., Hober, S., Rostami, E., Rasmusson, A., Cunningham, J. L., Havervall, S., Thalin, C., Manberg, A., Nilsson, P.
10.1101/2024.02.15.24302857 — Posted: 2024-02-15
COVID-19 VACCINATION-INFECTION STATUS AND IMMUNOLOGICAL PROFILE: IDENTIFICATION OF HIGH RISK POPULATION FOR TARGETED BOOSTER IMMUNIZATION IN INDIA
Gujjarlapudi, D., Mittal, A., Gajapathi Raju, V. D., Veturi, S. Y., Talukdar, R., Banerjee, R., Jagtap, N., Krishnaiah, S., Veeraiah, N., Duvvur, N. R.
10.1101/2024.02.14.24302808 — Posted: 2024-02-15
Differential associations between SARS-CoV-2 infection, perceived burden of the pandemic and mental health in the German population-based cohort for digital health research
Steinmann, L. A., Claass, L. V., Rau, M., Massag, J., Diexer, S., Klee, B., Gottschick, C., Binder, M., Sedding, D., Frese, T., Girndt, M., Hoell, J., Moor, I., Rosendahl, J., Gekle, M., Mikolajczyk, R., Opel, N.
10.1101/2024.02.14.24302768 — Posted: 2024-02-15
SARS-CoV-2 serosurvey of healthy, privately owned cats presenting to a New York City animal hospital in the early phase of the COVID-19 pandemic (2020-2021)
Choi, A., Stout, A. E., Rollins, A., Wang, K., Guo, Q., Jaimes, J. A., Kennedy, M., Wagner, B., Whittaker, G. R.
10.1101/2024.02.13.580068 — Posted: 2024-02-15
Immune escape of Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, XBB.1.5, EG.5.1 and JN.1.1 after vaccination, infection and hybrid immunity
Bekliz, M., Essaidi-Laziosi, M., Adea, K., Hosszu-Fellous, K., Alvarez, C., Bellon, M., Sattonnet-Roche, P., Puhach, O., Dbeissi, D., Zaballa, M. E., Stringhini, S., Guessous, I., Vetter, P., Eberhardt, C. S., Kaiser, L., Eckerle, I.
10.1101/2024.02.14.579654 — Posted: 2024-02-15
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model
Prakash, S., Dhanushkodi, N. R., Singer, M., Quadiri, A., Zayou, L., Vahed, H., Coulon, P.-G., El Babsiri, A., Gil, D., Ulmer, J. B., BENMOHAMED, L.
10.1101/2024.02.14.580225 — Posted: 2024-02-15
Difference in TMPRSS2 usage by Delta and Omicron variants of SARS-CoV-2: Implication for a sudden increase among children
Kakee, S., Kanai, K., Tsuneki-Tokunaga, A., Okuno, K., Namba, N., Tomita, K., Chikumi, H., Kageyama, S.
10.1101/2024.02.13.24302758 — Posted: 2024-02-14
Phase II/III Double-Blind Study Evaluating Safety and Immunogenicity of a Single Intramuscular Booster Dose of the Recombinant SARS-CoV-2 Vaccine "Patria" (AVX/COVID-12) Using an Active Newcastle Disease Viral Vector (NDV) during the Omicron Outbreak in Healthy Adults with Elevated Baseline Antibody Titers from Prior COVID-19 and/or SARS-CoV-2 Vaccination
Lopez-Macias, C., Torres, M., Armenta-Copca, B., Wacher, N. H., Galindo-Fraga, A., Castro-Castrezana, L., Colli-Dominguez, A. A., Cervantes-Trujano, E., Rucker-Joerg, I. E., Lozano-Patino, F., Rivera-Alcocer, J. J., Simon-Campos, A., Sanchez-Campos, E. A., Aguirre-Rivero, R., Muniz-Carvajal, A. J., del Carpio-Orantes, L., Marquez-Diaz, F., Rivera-Hernandez, T., Torres-Flores, A., Ramirez-Martinez, L., Paz-De la Rosa, G., Rojas-Martinez, O., Suarez-Martinez, J. A., Peralta-Sanchez, G., Carranza, C., Juarez, E., Zamudio-Meza, H., Carreto-Binaghi, L. E., Viettri, M., Romero-Rodriguez, D., Palenci
10.1101/2024.02.11.24302530 — Posted: 2024-02-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).